Detalhe da pesquisa
1.
Patient-Reported Outcomes in OlympiA: A Phase III, Randomized, Placebo-Controlled Trial of Adjuvant Olaparib in gBRCA1/2 Mutations and High-Risk Human Epidermal Growth Factor Receptor 2-Negative Early Breast Cancer.
J Clin Oncol
; 42(11): 1288-1300, 2024 Apr 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-38301187
2.
Prevalence and clinical impact of tumor BRCA1 and BRCA2 mutations in patients presenting with localized or metastatic hormone-sensitive prostate cancer.
Prostate Cancer Prostatic Dis
; 25(2): 199-207, 2022 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-34108647
3.
BRCA gene mutations do not shape the extent and organization of tumor infiltrating lymphocytes in triple negative breast cancer.
Cancer Lett
; 450: 88-97, 2019 05 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-30797818